JOHN MONAHAN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Theriva Biologics, Inc.

Filing Date Source Excerpt
2021-08-16 John Monahan 74 Director 2020 (1) Member of the Audit Committee. (2) Member of the Compensation Committee. (3) Member of the Nominations Committee. Dr. Monahan was appointed as a director on November 11, 2020. Fees in the director compensation chart do not include $11,250 for consulting fees earned for services provided during 2020 prior to his appointment as a director. John Monahan Fees Earned or Paid in Cash $ 9,251 Option Awards $ 40,086 Other Compensation - Total $ 49,337
2022-08-16 John Monahan(1)(2)(3) 75 Director 2020 (1) Member of the Audit Committee (2) Member of the Compensation Committee (3) Member of the Nominations Committee During 2021, each non-employee member of the Board of Directors received an annual cash retainer of $43,000, our independent, non-executive Chairman of the Board of Directors receives an annual cash retainer of $150,000, all non-employee directors receive an annual cash fee of $7,500, $5,000 and $3,750 for service on the Audit, Compensation and Nominations Committees, respectively, and the Chairman of the Audit, Compensation and Nominations Committees receive an additional annual cash fee of $15,000, $10,000 and $7,500, respectively. In addition, during 2021 each non-employee member of the Board of Directors was issued an option exercisable for 20,000 shares of Common Stock, for a term of seven years, vesting monthly over one year of the date of grant. The following table sets forth information for the fiscal year ended December 31, 2021 regarding the compensation of our directors who at December 31, 2021 were not also our Named Executive Officers. John Monahan $66,250 Fees Earned or Paid in Cash, $44,374 Option Awards, Total $110,624.
2023-08-14 Dr. Monahan has been a member of the Company's Board of Directors since November 11, 2020. The following table sets forth information for the fiscal year ended December 31, 2022 regarding the compensation of our directors who at December 31, 2022 were not also our Named Executive Officers. John Monahan received $66,750 in cash and $40,629 in option awards, totaling $107,379.
2024-09-30 John Monahan, 77, Director since 2020. Member of the Audit Committee, Compensation Committee, and Chairman of the Nominations Committee. Director compensation: $66,750 fees earned in cash, $43,756 option awards, total $110,506.

Data sourced from SEC filings. Last updated: 2026-02-03